Spruce Biosciences, Inc.

NASDAQ:SPRB

Biotechnology

Healthcare
$40.49 +5.07%

+$2.47 today

Market cap
$116.37M
Beta
3.20
P/E (TTM)
-1.9
EPS (TTM)
-$27.11
52W Low $7.00High $838.13

Volume 0.05M

Average 0.06M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$36.51M

FY 2025 · Annual

Net Income

-$38.97M

FY 2025 · Annual

Income Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Revenue0010.09M4.91M0
Cost of Revenue00000
Gross Profit0010.09M4.91M0
Gross Margin——100.0%100.0%—
Research & Development30.7M35.2M49.43M46.42M19.52M
Selling, General & Admin11.37M12.09M12.65M14.64M16.99M
Operating Expenses42.07M47.28M62.08M61.06M36.51M
Depreciation & Amortization68K74K70K46K21K
EBITDA(41.88M)(45.69M)(47.37M)(52.68M)(38.86M)
EBITDA Margin——-469.5%-1072.8%—
Operating Income(42.07M)(47.28M)(51.99M)(56.15M)(36.51M)
Operating Margin——-515.3%-1143.4%—
Interest Income119K1.52M4.56M3.42M1.14M
Interest Expense345K420K483K307K90K
Other Income / Expenses(226K)1.1M4.07M3.12M(2.45M)
Income Before Tax(42.29M)(46.18M)(47.92M)(53.04M)(38.97M)
Pre-Tax Margin——-475.0%-1079.9%—
Income Tax Expense00000
Net Income(42.29M)(46.18M)(47.92M)(53.04M)(38.97M)
Net Margin——-475.0%-1079.9%—
EPS (Basic)(68.25)(72.00)(93.00)(96.75)(50.83)
EPS (Diluted)(68.25)(72.00)(93.00)(96.75)(50.83)
Weighted Avg Shares607.4K611.71K500.63K536.44K766.6K
Weighted Avg Shares (Diluted)607.4K611.71K500.63K536.44K766.6K

SPRB Earnings Waterfall · TTM

NASDAQ:SPRB · Revenue to Net Income

Key Ratios

EPS$-37.60
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.9
P/S Ratio0.0

Analysis

$0 of revenue converted into -$37.2M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-37.60, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
SC 13GSC 13G filingAug 14, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
SC 13GSC 13G filingAug 14, 2026

How much revenue does SPRB generate?

Spruce Biosciences, Inc. (SPRB) reported $0.00 of revenue in fiscal 2025.

Is SPRB profitable?

Spruce Biosciences, Inc. (SPRB) reported -$38.97M of net income.